CoChat

17β‐hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone‐dependent breast cancer

Day, Joanna M., Foster, Paul A., Tutill, Helena J., Parsons, Michael F.C., Newman, Simon P., Chander, Surinder K., Allan, Gillian M., Lawrence, Harshani R., Vicker, Nigel, Potter, Barry V.L., Reed, Michael J., Purohit, Atul · 2008 · International Journal of Cancer
Cited by 107

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Oestradiol (E2) stimulates the growth of hormone‐dependent breast cancer. 17β‐hydroxysteroid dehydrogenases (17β‐HSDs) catalyse the pre‐receptor activation/inactivation of hormones and other substrates. 17β‐HSD1 converts oestrone (E1) to active E2, but it has recently been suggested that another 17β‐HSD, 17β‐HSD12, may be the major enzyme that catalyses this reaction in women. Here we demonstrate that it is 17β‐HSD1 which is important for E2 production and report the inhibition of E1‐stimulated breast tumor growth by STX1040, a non‐oestrogenic selective inhibitor of 17β‐HSD1, using a novel murine model. 17β‐HSD1 and 17β‐HSD12 mRNA and protein expression, and E2 production, were assayed in wild type breast cancer cell lines and in cells after siRNA and cDNA transfection. Although 17β‐HSD12 was highly expressed in breast cancer cell lines, only 17β‐HSD1 efficiently catalysed E2 formation. The effect of STX1040 on the proliferation of E1‐stimulated T47D breast cancer cells was determined in vitro and in vivo. Cells inoculated into ovariectomised nude mice were stimulated using 0.05 or 0.1 μg E1 (s.c.) daily, and on day 35 the mice were dosed additionally with 20 mg/kg STX1040 s.c. daily for 28 days. STX1040 inhibited E1‐stimulated proliferation of T47D cells in vitro and significantly decreased tumor volumes and plasma E2 levels in vivo. In conclusion, a model was developed to study the inhibition of the major oestrogenic 17β‐HSD, 17β‐HSD1, in breast cancer. Both E2 production and tumor growth were inhibited by STX1040, suggesting that 17β‐HSD1 inhibitors such as STX1040 may provide a novel treatment for hormone‐dependent breast cancer. © 2008 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.23350

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 45

  1. 10.1016/j.mce.2005.12.007 · DOI · Paper page
  2. 10.1016/j.mce.2005.11.031 · DOI
  3. Reed MJ, 1994, Regulation of estradiol 17β‐hydroxysteroid dehydrogenase expression and activity by retinoic acid in T47D breast cancer cells, Endocrinology, 135, 4, 10.1210/endo.135.1.8013376 · doi:10.1210/endo.135.1.8013376 · Paper page
  4. 10.1677/jme.1.02043 · DOI
  5. 10.1210/me.2005-0058 · DOI · Paper page
  6. 10.1074/jbc.M211684200 · DOI · Paper page
  7. 10.1016/j.jsbmb.2006.06.015 · DOI
  8. 10.1002/ijc.1525 · DOI · Paper page
  9. 10.1054/bjoc.1999.0956 · DOI · Paper page
  10. 10.1007/s10549-006-9198-8 · DOI
  11. 10.1016/j.mce.2005.12.005 · DOI
  12. 10.1038/sj.bjc.6602375 · DOI · Paper page
  13. 10.1158/0008-5472.CAN-06-1448 · DOI · Paper page
  14. 10.1016/j.mce.2005.12.003 · DOI
  15. 10.2174/0929867033368222 · DOI · Paper page
  16. 10.1007/978-3-642-60107-1_13 · DOI
  17. 10.1210/er.2004-0015 · DOI · Paper page
  18. 10.1158/1078-0432.CCR-04-2187 · DOI · Paper page
  19. 10.1158/1078-0432.CCR-05-1996 · DOI · Paper page
  20. 10.1158/1078-0432.CCR-06-0632 · DOI · Paper page
  21. 10.1016/S0960-0760(03)00353-4 · DOI
  22. 10.1016/j.mce.2005.10.021 · doi:10.1016/j.mce.2005.10.021
  23. 10.1021/jm050830t · DOI
  24. 10.1021/jm050348a · DOI
  25. 10.1021/jm049045r · DOI
  26. 10.1002/cmdc.200500087 · DOI
  27. 10.1016/0960-0760(95)00207-3 · DOI
  28. 10.1016/j.mce.2006.01.011 · DOI
  29. 10.1016/S0969-2126(96)00098-6 · DOI · Paper page
  30. 10.1093/nar/28.1.235 · DOI · Paper page
  31. 10.1038/nrd1031 · DOI · Paper page
  32. 10.1016/j.breast.2006.01.001 · DOI
  33. Purohit A, 2000, In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea‐induced mammary tumors by 667 COUMATE, Cancer Res, 60, 3394
  34. 10.1016/j.jsbmb.2007.03.001 · DOI
  35. Tang CK, 1999, Ribozyme‐mediated down‐regulation of ErbB‐4 in estrogen receptor‐positive breast cancer cells inhibits proliferation both in vitro and in vivo, Cancer Res, 59, 5315
  36. 10.1023/A:1005947024666 · doi:10.1023/a:1005947024666
  37. 10.1111/j.1432-1033.1996.00482.x · DOI · Paper page
  38. Ghersevich S, 1994, Rat 17β‐hydroxysteroid dehydrogenase type 1: primary structure and regulation of enzyme expression in rat ovary by diethylstilbestrol and gonadotropins in vivo, Endocrinology, 135, 1477, 10.1210/endo.135.4.7925110 · doi:10.1210/endo.135.4.7925110 · Paper page
  39. 10.1677/jme.1.01567 · DOI
  40. Yue W, 1994, A new nude mouse model for postmenopausal breast cancer using MCF‐7 cells transfected with the human aromatase gene, Cancer Res, 54, 5092
  41. 10.1021/jm058235e · DOI
  42. 10.1016/S0009-2797(02)00184-9 · DOI
  43. 10.1016/j.mce.2005.11.037 · DOI
  44. 10.1016/j.mce.2005.11.042 · DOI
  45. 10.1172/JCI106862 · DOI · Paper page

Cited by

See all 107

Metadata

Authors
Day, J. M., Foster, P. A., Tutill, H. J., Parsons, M. F. C., Newman, S. P., Chander, S. K., Allan, G. M., Lawrence, H. R., Vicker, N., Potter, B. V. L., Reed, M. J., & Purohit, A.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2008-02-25
Volume
122
Issue
9
Pages
1931-1940
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2053405000
Cited by
107
References
5
FWCI
9.32
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 17β‐hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone‐dependent breast cancer. https://app.cochat.ai/papers/10.1002/ijc.23350
The paper
Day, J. M., Foster, P. A., Tutill, H. J., Parsons, M. F. C., Newman, S. P., Chander, S. K., Allan, G. M., Lawrence, H. R., Vicker, N., Potter, B. V. L., Reed, M. J., & Purohit, A. (2008). 17β‐hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone‐dependent breast cancer. International Journal of Cancer. https://doi.org/10.1002/ijc.23350

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.